Hyperion DeFi (HYPD) Form 4: 50,000 RSUs Awarded to Director
Rhea-AI Filing Summary
Rachel Jacobson, a director of Hyperion DeFi, Inc. (HYPD), was granted 50,000 restricted stock units (RSUs) on 08/18/2025. The RSUs are non‑cash awards that vest in three tranches: 25,000 on December 15, 2025; 12,500 on May 26, 2026; and 12,500 on August 16, 2026. All RSUs will vest immediately if a defined Corporate Transaction occurs or if Ms. Jacobson’s board service ends for any reason other than her voluntary resignation. After the grant, Ms. Jacobson beneficially owns 56,301 shares. The filing is a Form 4 disclosure signed and dated 08/20/2025.
Positive
- Director alignment: Grant of 50,000 RSUs aligns the reporting director’s interests with shareholders through equity incentives
- Clear vesting and acceleration: Vesting schedule and immediate vesting upon Corporate Transaction or involuntary board exit are explicitly disclosed
- Transparency: Filing discloses post‑grant beneficial ownership of 56,301 shares
Negative
- Potential dilution: The grant increases outstanding equity obligations, though the Form 4 does not state total outstanding shares or percentage impact
- Missing compensation details: The filing does not disclose grant fair value, accounting expense, or board approval details
Insights
TL;DR: Director granted time‑based RSUs with change‑in‑control and termination vesting provisions; typical executive compensation structure.
The award aligns a director’s interests with shareholders through equity compensation that vests over 8–12 months and accelerates on a Corporate Transaction or involuntary termination. This structure is common for board retention and for aligning incentives around exit events. The post‑grant beneficial ownership of 56,301 shares provides transparency on insider holdings. There is no disclosure here of grant fair value, expense recognition, or whether the grant was approved by disinterested directors, so governance implications are limited to the vesting and acceleration mechanics explicitly stated.
TL;DR: 50,000 RSUs issued to a director, vesting schedule provided; impact appears routine and non‑dilutive at material levels.
The filing documents a non‑derivative grant of 50,000 RSUs at $0 cash price and specifies vesting dates and acceleration triggers. Such grants are routine for board compensation and retention. The disclosure lists 56,301 shares beneficially owned after the transaction, which helps investors assess insider exposure. The Form 4 does not include reserve pool size, percentage of outstanding common stock, or accounting details, limiting assessment of dilution and expense impact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $.0001 | 50,000 | $0.00 | -- |
Footnotes (1)
- [object Object]